Multiple Dose Study With Incremental Dosing to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Doses of LEO 32731 in Healthy Male Japanese Subjects.
Clinical trial NCT03231124 · COMPLETED
Trial details
- NCT number
- NCT03231124
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2017-08-22
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.